Common genetic variants near <i>SLC2A2</i> and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial
- DOI
- 10.1101/2025.10.07.25336827
- Published
- 2025-10-08
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1101/2025.10.07.25336827,
title = {Common genetic variants near
<i>SLC2A2</i>
and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial},
author = {Josephine H. Li and Lukasz Szczerbinski and Mark Tripputi and Haiyin Liu and Stella Nam and Endrina Mujica and Anastasia Emmanouilidou and Thinley Yidzin Wangden and Anna Citko-Rojewska and Paulina Konopka and Marcin Czajkowski and Alicia Huerta-Chagoya and Maheak Vora and Aaron Leong and James B. Meigs and Maggie Y. Ng and Ruth J.F. Loos and Marie Pigeyre and Hertzel C. Gerstein and Filipe A. Moura and Yi-Pin Lai and Deepak L. Bhatt and Nicholas A. Marston and Christian T. Ruff and Marc S. Sabatine and Adam Y. Dawed and Ewan R. Pearson and Leslie S. Satin and Marcel den Hoed and Adam Kretowski and Steven E. Kahn and Naji Younes and Josep M. Mercader and Jose C. Florez and Unknown},
year = {2025},
doi = {10.1101/2025.10.07.25336827},
url = {https://doi.org/10.1101/2025.10.07.25336827}
}RIS
TY - JOUR
TI - Common genetic variants near
<i>SLC2A2</i>
and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial
AU - Josephine H. Li
AU - Lukasz Szczerbinski
AU - Mark Tripputi
AU - Haiyin Liu
AU - Stella Nam
AU - Endrina Mujica
AU - Anastasia Emmanouilidou
AU - Thinley Yidzin Wangden
AU - Anna Citko-Rojewska
AU - Paulina Konopka
AU - Marcin Czajkowski
AU - Alicia Huerta-Chagoya
AU - Maheak Vora
AU - Aaron Leong
AU - James B. Meigs
AU - Maggie Y. Ng
AU - Ruth J.F. Loos
AU - Marie Pigeyre
AU - Hertzel C. Gerstein
AU - Filipe A. Moura
AU - Yi-Pin Lai
AU - Deepak L. Bhatt
AU - Nicholas A. Marston
AU - Christian T. Ruff
AU - Marc S. Sabatine
AU - Adam Y. Dawed
AU - Ewan R. Pearson
AU - Leslie S. Satin
AU - Marcel den Hoed
AU - Adam Kretowski
AU - Steven E. Kahn
AU - Naji Younes
AU - Josep M. Mercader
AU - Jose C. Florez
AU - Unknown
PY - 2025
DO - 10.1101/2025.10.07.25336827
UR - https://doi.org/10.1101/2025.10.07.25336827
ER - APA
Li, J. H., Szczerbinski, L., Tripputi, M., Liu, H., Nam, S., Mujica, E., Emmanouilidou, A., Wangden, T. Y., Citko-Rojewska, A., Konopka, P., Czajkowski, M., Huerta-Chagoya, A., Vora, M., Leong, A., Meigs, J. B., Ng, M. Y., Loos, R. J., Pigeyre, M., Gerstein, H. C., Moura, F. A., Lai, Y., Bhatt, D. L., Marston, N. A., Ruff, C. T., Sabatine, M. S., Dawed, A. Y., Pearson, E. R., Satin, L. S., Hoed, M. D., Kretowski, A., Kahn, S. E., Younes, N., Mercader, J. M., Florez, J. C., & Unknown (2025). Common genetic variants near <i>SLC2A2</i> and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial. https://doi.org/10.1101/2025.10.07.25336827
Source records
- crossref · retrieved 2026-09-26T17:12:30.905Z